Biotech

All Articles

ArsenalBio raises $325M, turns away from past lead property

.Toolbox Biosciences is actually carrying on up. The cell therapy provider has actually added $325 t...

Lilly- backed effective weight loss biotech documents IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...

Aelis' cannabis usage medication flunks stage 2b, driving Indivior to re-think $100M possibility

.Aelis Farma's hopes of getting a quick, beneficial choice on a $one hundred thousand alternative re...

ProKidney standstills phase 3 trial not required for cell therapy confirmation

.ProKidney has actually ceased among a set of period 3 tests for its tissue therapy for renal health...

Vaxcyte surges on 'stunning' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what professionals referred to as "magnificent" stage 1/2 data for its own 31-va...

Recursion's brain disease test shows scant documentation of efficacy

.Recursion has actually discovered with a very early test of its tech-enabled method to medication r...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Call it a case of great chemical make up: Acepodia, a biotech based on Nobel Champion scientific re...

Praxis epilepsy medication lowers seizures in phase 2 hearing

.Praxis Accuracy Medicines has scored one more midphase succeed in epilepsy this year, with its sodi...

Three execs resign as Dyne messages blended records for DMD candidate

.After getting away a medical grip several years back, Dyne Rehab has revealed new stage 1/2 informa...

Arrowhead fires off stage 3 records in unusual metabolic disease in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its own hand in advance of a possible face-off along with Ionis...